ID
32684
Description
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
Versions (2)
- 11/12/18 11/12/18 -
- 11/12/18 11/12/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 12, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Estimation of Dose Proportionality of Darapladib - 107038
12-lead ECG Form
- StudyEvent: ODM
Description
Timepoint 1
Description
Date of ECG
Data type
date
Description
Time of ECG
Data type
time
Description
Heart rate
Data type
integer
Description
PR Interval
Data type
float
Measurement units
- msec
Description
QRS Duration
Data type
float
Measurement units
- msec
Description
Uncorrected QT Interval
Data type
float
Measurement units
- msec
Description
QTc Interval
Data type
float
Description
Method of QTc Calculation
Data type
text
Description
Result of the ECG
Data type
text
Similar models
12-lead ECG Form
- StudyEvent: ODM